Institutional Sign In

Go

Bayer Czech Republic - Total Asset Growth

Bayer CR`s Total Asset Growth reached -3.71 % in 2017. This is 108 % less than in the previous year.

$1.99

Buy Total Asset Growth data for Bayer Czech Republic.

$19.99

Buy all data for Bayer Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ...           36.5 14.1 -15.6 22.4 3.28    
Bayer Czech Republic % ... ... ...               -41.7 -26.0 22.0 -2.28 21.7    
GlaxoSmithKline Czech Republic % ... ... ...               15.9 -23.6 -1.81 -15.0 4.34    
Merck Czech Republic % ... ...                 25.8 12.5 8.86 -12.5 11.3    
Novartis Czech Republic %                     12.2 8.05 -0.432 9.23 16.1    
Pfizer Czech Republic % ... ...                 -3.91 -12.3 11.1 3.91 -33.7    
Roche Czech Republic % ... ... ...               -9.52 4.74 -4.23 3.23 9.98   ...
Sanofi-Aventis Czech Republic % ... ... ... ...             1.84 4.11 -18.3 -12.8 12.2    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... 15.0 129 13.3    
Walmark % ... ... ...               -2.00 -7.16 23.1 6.71 -23.3